Center for Assisted Reproduction, Krishna IVF Clinic, Visakhapatnam, India.
Department of Biotechnology, Institute of Science, Gitam (Deemed to be) University, Visakhapatnam, India.
Front Endocrinol (Lausanne). 2021 May 11;12:628169. doi: 10.3389/fendo.2021.628169. eCollection 2021.
Infertility is a major concern for couples wanting to have progeny. Despite recent advances in the field of IVF, success rates still need improvement. Understanding the patient's variability and addressing it with personalized interventions may improve the success rate of fertilization and live births. This study examined the impact of a personalized pharmacogenomic approach on LH supplementation on the pregnancy and live birth rate outcomes in comparison with the traditional approaches. 193 patients undergoing a second IVF cycle in Krishna IVF Clinic received LH supplementation either as per the conventional methods or based on N312S (rs2293275) LHCGR gene polymorphism. Results showed a significant increase in pregnancy rate (P-value: 0.049) and a trend showing improvement in live birth rates (P-value: 0.082) when r-hLH supplementation protocol was decided as per the genotypes A/A, A/G, and G/G of the N312S variant in the respective patients. This stimulation regimen helped in providing optimum levels of r-hLH supplementation to patients with impaired hormone-receptor interacting activity, to achieve higher success in pregnancy and live birth rates.
不孕不育是许多夫妇关注的重大问题,他们希望生育后代。尽管最近在试管婴儿技术领域取得了进展,但成功率仍有待提高。了解患者的个体差异,并通过个性化干预措施来解决这些差异,可能会提高受精和活产的成功率。本研究比较了传统方法和个性化药物基因组学方法对 LH 补充对妊娠和活产率结局的影响。在 Krishna IVF 诊所接受第二次试管婴儿周期的 193 名患者,根据常规方法或 N312S(rs2293275)LHCGR 基因多态性,接受 LH 补充。结果表明,当根据 N312S 变异的基因型 A/A、A/G 和 G/G 决定 r-hLH 补充方案时,妊娠率显著增加(P 值:0.049),活产率也呈上升趋势(P 值:0.082)。这种刺激方案有助于为激素受体相互作用活性受损的患者提供最佳水平的 r-hLH 补充,以提高妊娠和活产率的成功率。